Colleen Labelle, MSN
Assistant Professor
Boston University School of Medicine
Dept of Medicine
General Internal Medicine

MSN, Grand Canyon College
RN, St Elizabeths Hosp

09/12/2019 - 05/31/2024 (PI)
Kaiser Foundation Research Inst NIH-NIMH

Office Based Opioid Treatment
07/01/2017 - 06/30/2022 (PI)

Primary Care Opoid Use Disorders Treatment(PROUD) Trial YR02
06/01/2020 - 02/28/2022 (PI)
Kaiser Permanente National Institute o

Treating Chronic Pain in Buprenorphine Patients in Primary C
02/15/2019 - 01/31/2022 (PI)
Trustees of Boston University, BUMC National Institutes

BOBAT - NCM-OBAT Training and Technical Assistance
09/30/2018 - 09/29/2021 (PI)
Signature Healthcare Brockton Hospital HRSA-SAMHSA

OBOT Training and Technical Assistance_YR4
07/01/2020 - 06/30/2021 (PI)
Massachusetts Dept. of Public Health / DPH Substance Abuse and

OBOT Training and Technical Assistance
10/01/2014 - 06/30/2021 (PI)

BMC OBAT Training and Technical Assistance (OBAT TTA) - SUSTAIN TTA PLUS
03/01/2019 - 02/28/2021 (PI)
GE Healthcare

Primary Care Opoid Use Disorders Treatment(PROUD) Trial_YR5
06/01/2016 - 02/28/2021 (PI)
Kaiser Permanente National Institute o

S2 - State Technical Assistance Team Education and Support
02/01/2019 - 01/31/2021 (PI)
American Academy of Addiction Psychiatry HRSA-SAMHSA

Showing 10 of 21 results. Show All Results


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Komaromy M, Tomanovich M, Taylor JL, Ruiz-Mercado G, Kimmel SD, Bagley SM, Saia KM, Costello E, Park TW, LaBelle C, Weinstein Z, Walley AY. Adaptation of a System of Treatment for Substance Use Disorders During the COVID-19 Pandemic. J Addict Med. 2021 Nov-Dec 01; 15(6):448-451.View Related Profiles. PMID: 33298750; DOI: 10.1097/ADM.0000000000000791;
  2. Wason K, Potter A, Alves J, Loukas VL, Lastimoso C, Sodder S, Caputo A, LaBelle CT. Addiction Nursing Competencies: A Comprehensive Toolkit for the Addictions Nurse. J Nurs Adm. 2021 Sep 01; 51(9):424-429.View Related Profiles. PMID: 34411061
  3. Tsui JI, Leroux BG, Radick AC, Schramm ZA, Blalock K, Labelle C, Heerema M, Klein JW, Merrill JO, Saxon AJ, Samet JH, Kim TW. Video directly observed therapy for patients receiving office-based buprenorphine - A pilot randomized controlled trial. Drug Alcohol Depend. 2021 10 01; 227:108917.View Related Profiles. PMID: 34399136; PMCID: PMC8464515; DOI: 10.1016/j.drugalcdep.2021.108917;
  4. Campbell CI, Saxon AJ, Boudreau DM, Wartko PD, Bobb JF, Lee AK, Matthews AG, McCormack J, Liu DS, Addis M, Altschuler A, Samet JH, LaBelle CT, Arnsten J, Caldeiro RM, Borst DT, Stotts AL, Braciszewski JM, Szapocznik J, Bart G, Schwartz RP, McNeely J, Liebschutz JM, Tsui JI, Merrill JO, Glass JE, Lapham GT, Murphy SM, Weinstein ZM, Yarborough BJH, Bradley KA. PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment. Addict Sci Clin Pract. 2021 01 31; 16(1):9.View Related Profiles. PMID: 33517894; PMCID: PMC7849121; DOI: 10.1186/s13722-021-00218-w;
  5. Bagley SM, Cheng DM, Winter M, Alford DP, LaBelle C, Walley AY, Samet JH. Opioid and cocaine use among primary care patients on buprenorphine-Self-report and urine drug tests. Drug Alcohol Depend. 2018 11 01; 192:245-249.View Related Profiles. PMID: 30290291; PMCID: PMC6291245; DOI: 10.1016/j.drugalcdep.2018.08.010;
  6. Weinstein ZM, Gryczynski G, Cheng DM, Quinn E, Hui D, Kim HW, Labelle C, Samet JH. Tapering off and returning to buprenorphine maintenance in a primary care Office Based Addiction Treatment (OBAT) program. Drug Alcohol Depend. 2018 08 01; 189:166-171.View Related Profiles. PMID: 29958128; PMCID: PMC6139651; DOI: 10.1016/j.drugalcdep.2018.05.010;
  7. Hui D, Weinstein ZM, Cheng DM, Quinn E, Kim H, Labelle C, Samet JH. Very early disengagement and subsequent re-engagement in primary care Office Based Opioid Treatment (OBOT) with buprenorphine. J Subst Abuse Treat. 2017 Aug; 79:12-19.View Related Profiles. PMID: 28673522; PMCID: PMC5522736; DOI: 10.1016/j.jsat.2017.05.010;
  8. Weinstein ZM, Kim HW, Cheng DM, Quinn E, Hui D, Labelle CT, Drainoni ML, Bachman SS, Samet JH. Long-term retention in Office Based Opioid Treatment with buprenorphine. J Subst Abuse Treat. 2017 Mar; 74:65-70.View Related Profiles. PMID: 28132702; PMCID: PMC5312773; DOI: 10.1016/j.jsat.2016.12.010;
  9. LaBelle CT, Han SC, Bergeron A, Samet JH. Office-Based Opioid Treatment with Buprenorphine (OBOT-B): Statewide Implementation of the Massachusetts Collaborative Care Model in Community Health Centers. J Subst Abuse Treat. 2016 Jan; 60:6-13.View Related Profiles. PMID: 26233698; PMCID: PMC4682362; DOI: 10.1016/j.jsat.2015.06.010;
  10. Tierney M, Finnell DS, Naegle MA, LaBelle C, Gordon AJ. Advanced Practice Nurses: Increasing Access to Opioid Treatment by Expanding the Pool of Qualified Buprenorphine Prescribers. Subst Abus. 2015; 36(4):389-92. PMID: 26587696; DOI: 10.1080/08897077.2015.1101733;
Showing 10 of 18 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 18 publications over 11 distinct years, with a maximum of 4 publications in 2021

Contact for Mentoring:

801 Massachusetts Ave
Boston MA 02118
Google Map

Labelle's Networks
Click the "See All" links for more information and interactive visualizations
Media Mentions
Similar People
Same Department